RA CAPITAL MANAGEMENT L.P. 13D and 13G filings for Relmada Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -2,000,000 (Position Closed) | Filing |
| 2021-12-20 4:33 pm Purchase | 2021-12-09 | 13G | Relmada Therapeutics, Inc. RLMD | RA CAPITAL MANAGEMENT L.P. | 2,000,000 7.200% | 2,000,000 (New Position) | Filing |
| 2021-02-16 4:39 pm Sale | 2020-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -761,666 (Position Closed) | Filing |
| 2020-02-14 4:34 pm Purchase | 2019-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | RA CAPITAL MANAGEMENT L.P. | 761,666 5.400% | 761,666 (New Position) | Filing |